What doesn’t kill them, only makes them stronger

by Tapiwa Tarwa

For decades, the medical field has waged war against disease-causing bacteria. Armed with the (then) recent discovery of antimicrobials, medical professionals finally believed they had the upper hand. However; these bacteriae have proven to be a worthy opponent as they have quickly retaliated with antimicrobial resistance (AMR)*. This resistance is a weapon rendering nearly all antimicrobials ineffective. This leaves the health system defenceless against the persistence and spread of many deadly diseases. As the medical field continues to lose ground in the war against disease, it becomes more critical to understand the vast arsenal of tools at the bacteriae’s disposal – in particular, those that allow them to become resistant.

  • Antimicrobial resistance- the ability to resist the effects of antimicrobials that could  successfully treat the bacteria
  • Sequencing- a process of determining the DNA (genetics) of an organism
  • Niche- a comfort place for life
  • A battery of tests- a series of tests

Recent advances in the medical science field, especially those in sequencing*, have shed light on the biological properties that are altered (for example, through mutations) to allow for resistance. However, these advances fail to explain how such resistance occurs or spreads within a population during treatment. Researchers from Princeton University set out to mimic bacterial niches* and show the precise molecular mechanism that underpins the rapid emergence of antimicrobial resistance in bacteria [1,2].

In a two-paper series, the researchers conducted a battery* of experiments using many techniques to further the understanding of resistance. The main techniques included a microfluidic system (a technology that allows for precise manipulation of physiochemical conditions in bacterial cultures- temperature, nutrients, antibiotic concentrations, etc.) and time-lapse microscopy (series of images viewed at a higher speed to give an accelerated view of the microscopic process) [1,2].

In the first paper, the researchers used the microfluidic system to expose several E. coli to ciprofloxacin (a genotoxic antimicrobial) concentration gradient. This concentration gradient mimicked those seen in patients on treatment as it is often difficult to obtain adequate amounts of antibiotics at infection sites due to their location.  This experiment turned the current understanding of resistance on its head [1].

Resistant bacteria were thought to be already present in large populations of bacteria (i.e. 1 in 108). However, this experiment showed that resistant bacteria were not pre-existing in a sizeable bacterial population (a subpopulation) but were instead acquired as de novo mutations due to antimicrobial exposure (Figure 1) [1].

Figure 1. Bacterial density versus time, shown for initial inoculations of 106, 105, 104, 103, and 102 wildtype E. coli with ciprofloxacin (1 mg/ml) in the bottom channel [1].

The experiments indicated that given enough time, under these conditions, resistant bacteria would appear. These bacteriae would always appear with similar mutations, some known to increase fitness (increase the bacteria’s ability to survive/reproduce in the absence of the antimicrobial compared to susceptible bacteria) [3]. Contrary to common belief, resistant mutants did not first grow in the areas with the least antimicrobial concentration. They often first colonized areas with the highest antimicrobial concentration before growing in areas where antimicrobial concentration was low (Figure 2) [1]

Figure 2. (A to C) Initial inoculations of 106 wildtype bacteria with ciprofloxacin (10 mg/ml) in the bottom channel. (A) The emergence of resistance to ciprofloxacin ~5 hours after inoculation. The orange arrow shows the area with high antimicrobial concentration. (B) Spread of resistant bacteria around the periphery of the microenvironments at 10 hours after inoculation. (C) The continued growth of ciprofloxacin-resistant bacteria after 15 hours [1].

In the second paper, the researchers used a microfluidic system in combination with fluorescent time-lapse microscopy. The experiment involved fluorescently labelling the chromosomes of E. coli and exposing it to sub-minimal inhibitory concentrations (Sub-MIC*) of ciprofloxacin. Their paper highlighted that bacteria exposed to antimicrobials, underwent filamentation (a process where bacteria do not divide but continue to grow in length). Continued antimicrobial exposure would result in cell death or an increased length until the bacteria can divide asymmetrically at the tip (bud formation) (Figure 3). These buds would then divide as usual in the presence of antimicrobial (resistant) or fail to divide (contain damaged or no chromosome) [2].

MIC- Minimum inhibitory concentration -the lowest concentration of an antimicrobial that will inhibit bacterial growth


Additionally, the filamentous bacteria seemed to produce multiple chromosomes (polyploidy). The induction of the SOS response (a response traditionally thought to be a DNA repair mechanism) is required for the formation of filaments and multiple chromosomes. However, the researchers suggest that rather than stopping the cell cycle for repair, the SOS response engages a low fidelity polymerase[1] that continues to copy the chromosome generating mutations. The mutant chromosomes are then supposedly passed to the resistant progeny (Figure 4) [2].

Polymerase- an enzyme that is essential in replicating DNA


Figure 3. Time-lapse microscopy showing the movement of individual chromosomes (in red) along the filament length (Scale bar, 1 μm.) White arrowheads indicate events of merging/splitting between two chromosomes. The yellow arrowhead indicates a chromosome duplication/separation event. Dashed lines show the cell contours [2].

What does this all mean in the fight against bacteria? Well, it seems as though resistance is in their genes and they will not go down without a fight. As the medical field scramble for more weapons and tools to fight this worthy opponent, one thing is for sure- “what doesn’t kill the bacteria only makes them stronger.”  Thus, future interventions should not only aim to win the battle but rather the war.


Figure 4. The formation of resistance filaments. The light grey cells are initially sensitive cells, dark grey cells have double-strand breaks in the DNA and stalled replication forks, green cells have evolved moderate antibiotic resistance, and red cells are undergoing death. Chromosomes are within the cells [2].


  1. Zhang Q, Lambert G, Liao D, Kim H, Robin K, Tung CK, Pourmand N, Austin RH. Acceleration of emergence of bacterial antibiotic resistance in connected microenvironments. Science. 2011 Sep 23;333(6050):1764-7.
  2. Bos J, Zhang Q, Vyawahare S, Rogers E, Rosenberg SM, Austin RH. The emergence of antibiotic resistance from multinucleated bacterial filaments. Proceedings of the National Academy of Sciences. 2015 Jan 6;112(1):178-83.
  3. Baker S, Duy PT, Nga TV, Dung TT, Phat VV, Chau TT, Turner AK, Farrar J, Boni MF. Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. Elife. 2013 Dec 10;2: e01229.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s